ZWZulong Wang

Zulong Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zulong Wang has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Shiqi Wang

    Department of Hematology and Oncology, The First Affiliated Hospital of Henan University of Chinese Medicine

    8 shared publications
  • Chenming Zhang

    Henan University of Chinese Medicine

    7 shared publications
  • Sicheng Ma

    Traditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, Henan, China

    7 shared publications
  • Hao Zhang

    Faculty of Chinese Medicine, Macau University of Science and Technology

    6 shared publications
  • Rubing Chen

    Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine

    6 shared publications
  • Zhong Hua

    Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China

    5 shared publications

Latest Publications

  • Open Access

    Testosterone-related indices and adverse glucose-lipid metabolic status in men: a single-center retrospective study

    by Miaomiao Ma, Qi Zhang, Zulong Wang, Baojun Ju, Shiqi Wang, Zhang Hao, Kaibo Su, Rubing Chen, Wenbo Zhang

    Background: Lower testosterone is often observed with abnormal glucose-lipid metabolism, but the clinical value of calculated testosterone fractions in metabolic assessment remains uncertain. This study evaluated cross-sectional associations of total testosterone (TT), calculated free testosterone (FT), free testosterone percentage (FT%), bioavailable testosterone (BioT), bioavailable testosterone percentage (BioT%), and sex hormone-binding globulin (SHBG) with glucose-lipid traits in male andrology outpatients. Methods: This single-center retrospective cross-sectional analysis included 420 adult male andrology outpatients with complete records for TT, SHBG, albumin, glucose, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C). Age-adjusted partial Spearman correlations, rank-standardized regression, SHBG-adjusted models, restricted cubic spline analysis, age-stratified interaction analysis, sensitivity analyses, and exploratory machine learning-assisted validation were performed. Results: TT was inversely associated with glucose and TG and positively associated with HDL-C. FT% and BioT% were positively associated with TG and inversely associated with HDL-C, but these associations were markedly attenuated or reversed after additional adjustment for SHBG. Restricted cubic spline models supported approximately linear associations of TT with glucose, TG, and HDL-C. In machine learning-assisted validation, adverse glucose-lipid metabolic status was present in 285 participants (67.9%). The Age + TT + SHBG model and XGBoost showed modest discrimination, with AUCs of 0.691 and 0.688, respectively. SHAP analysis suggested SHBG and age were the strongest model contributors, but this ranking should be interpreted as exploratory because correlated predictors can affect SHAP-based importance estimates. Conclusions: In male andrology outpatients, lower TT was associated with an adverse glucose-lipid profile, particularly higher glucose and TG and lower HDL-C. Percentage-based calculated testosterone indices appeared to reflect SHBG-dependent redistribution of circulating testosterone rather than an independent favorable androgen state. Machine learning-assisted validation further supported the interpretive importance of SHBG, although prediction performance remained exploratory. These findings should be interpreted within a single-center outpatient cohort and should not be generalized directly to the broader male population.

  • Open Access

    Animal models of gut microbiota–male reproductive interactions: methodological assessment, translational bottlenecks, and optimization strategies

    by Yong Ma, Xuewen Diao, Zulong Wang

    Idiopathic infertility accounts for 30%–40% of male infertility cases, yet its etiology remains largely unexplained. The gut–testis axis hypothesis has recently emerged as a promising direction, with human cohort studies revealing statistical associations between gut dysbiosis and impaired semen quality. However, establishing mechanistic and causal evidence beyond observational associations requires complementary approaches, including animal models. Whether current models adequately capture the chronic, low-grade nature of gut-derived insults that may contribute to idiopathic infertility remains insufficiently examined. Here, we examine the methodological foundations of gut–testis axis animal models. We organize them according to the tier of causal question they address and evaluate their internal, external, and construct validity. Our analysis identifies a recurring pattern in which some existing models, particularly those testing the effects of individual molecular pathways, employ exposure magnitudes, routes, and time scales that may not fully reflect the prolonged, low-intensity disturbances hypothesized in gut-driven reproductive injury. The collective efforts of these model categories have identified several signaling axes that, under defined experimental conditions, can measurably affect the testis. However, the internal and external validity limitations of many of these models warrant caution when interpreting these demonstrations of conditional biological capacity as direct evidence that the same pathways carry etiological weight in human idiopathic infertility. To bridge this gap, we propose a logical framework for evaluating causal evidence that transitions from establishing a pathway’s biological capacity to assessing its etiological contribution. This framework is anchored on three criteria: endogenous signal origin, pathomimetic exposure profile, and attributive exclusivity. We further propose a preliminary reporting framework, termed Minimal Information for Gut–Testis Axis Rodent Studies (MIGTARS), to support more transparent and methodologically informative reporting. These proposals together provide a methodological scaffold for moving the gut–testis field from pathway verification toward translational modeling.

  • Open Access

    Clinical features and risk factors analysis of diabetes mellitus complicated with Peyronie’s disease

    by Yuanyuan Li, Xuewen Diao, Zulong Wang

    Background: The association between Diabetes Mellitus (DM) and Peyronie’s disease (PD), as well as the impact of DM on PD phenotypes, remains not fully elucidated. Aim: To investigate the association between PD and DM and to assess the impact of DM on the clinical phenotype of PD. Methods: This case–control study retrospectively enrolled 136 PD patients from Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine (December 2019 to May 2025) as the case group. Two control groups were established concurrently: andrology patients without PD and healthy examinees. To control for confounding bias, propensity score matching (PSM) was used to balance baseline characteristics. Logistic regression analysis was employed to determine the independent association between DM and PD. Furthermore, clinical characteristics were compared between PD patients with and without DM. Outcomes: This study evaluate the correlation between DM and PD, as well as the clinical manifestations of their comorbidity. Results: ① The prevalence of DM and the proportion of related risk factors were significantly higher in the case group (P < .05). ② After PSM, logistic regression confirmed an independent association between DM and PD (Model 1: OR = 2.815, 95% CI: 1.376-5.989; Model 2: OR = 3.436, 95% CI: 1.823-6.709). ③ Compared to the non-DM subgroup, PD patients in the DM subgroup had a greater number of plaques, higher plaque elasticity, and a larger curvature angle, but reported lower pain scores (all P < .05). Clinical Implications: This finding suggests that clinicians should be vigilant for occult yet structurally severe PD in diabetic patients and consider implementing multidisciplinary management strategies. Strengths and Limitations: The strengths of this study lie in its relatively large sample size of PD patients within the field of andrological rare diseases, the dual-control design, and the robust PSM analysis conducted. Limitations include its retrospective, single-center design and the potential for residual confounding factors. Conclusion: DM is independently associated with PD and is linked to a distinct clinical phenotype characterized by more severe fibrosis (more plaques, greater curvature) but diminished pain perception.

  • Open Access

    Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis

    by Rubing Chen, Huiyuan Shen, Chen Wang, Shiqi Wang, Baojun Ju, Zulong Wang

    This meta-analysis was conducted to systematically evaluate the efficacy and safety of combination therapy with alpha-adrenergic blockers (α-ABs) and

  • Top Cited Papers
    Open Access

    Rethinking network analysis in ethnopharmacology: a multi-omics and AI roadmap to overcome conceptual and methodological biases

    by Xuewen Diao, Hao Zhang, Shiqi Wang, Zulong Wang, Qi Zhang

    Network analysis (NA) is a widely used computational tool for exploring the complex systems of interactions in ethnopharmacology, aiming to predict potential targets and generate mechanistic hypotheses. However, the predictive validity and biological relevance of its outputs are constrained by a pervasive methodological bottleneck: the recurrent identification of a narrow set of molecules—such as quercetin—across disparate natural products and diseases. Through a systematic analysis of 1,038 network-based studies, we establish “homogeneity” as a coherent, multi-level pattern, from “Flavonoid Centrality” to a “Hub-Target Core” and restricted “Canonical Pathways,” transcending specific remedies or diseases. We conceptualize this as a self-reinforcing “convergent discovery pipeline,” in which initial database biases are amplified by context-insensitive analytical approaches. Empirical evidence shows that integrating contextual experimental or multi-omics data mitigates homogeneity. To break this cycle and align network analysis more closely with pharmacological best practices, we propose an integrated framework that shifts from database dependency to empirically driven data acquisition, leverages bias-aware artificial intelligence for curation and prioritization, and advances dynamic, context-specific network modeling. This framework provides a clear roadmap to disrupt methodological inertia and steer network-based research in ethnopharmacology toward a more robust, diverse, and pharmacologically and clinically relevant future.


  • Open Access

    Bridging ancient wisdom and modern technology: an AI and multi-omics framework for three causes tailored treatment in personalized medicine

    by Xuewen Diao, Hao Zhang, Shiqi Wang, Qi Zhang, Zulong Wang

    The ‘one-size-fits-all’ therapeutic model is inadequate to address individual patient variability, creating an urgent need for an integrative framework for precision medicine. The ‘Three Causes Tailored Treatment’ (TCTT) principle from traditional Chinese medicine offers a time-tested, holistic blueprint that simultaneously considers the individual, temporal, and environmental dimensions of health. Here, we argue that the synergy of artificial intelligence (AI) and multi-omics technologies is the key to transforming this ancient wisdom into a modern, quantitative clinical paradigm. We demonstrate how multi-omics data provides the foundational layers to quantify the TCTT principle—for instance, using integrated omics (e.g., genomics, proteomics, microbiome) to establish the individual’s molecular baseline (“Who”); chronomics to capture temporal fluxes (“When”); and the exposome to decipher the internalized environmental imprint (“Where”)—while AI-powered multimodal integration models their complex interactions. By synthesizing evidence across the disease continuum, this review provides a translational roadmap for building dynamic clinical decision-support systems, thereby charting a course toward truly personalized, time-sensitive, and context-aware healthcare.


  • Open Access

    The effects of testicular aging on Leydig cells and the application of stem cells in restoring Leydig cells function

    by Wen-Bo Zhu, Han-Bin Zhao, Guang-Zhao Wang, Zu-Long Wang, Shi-Qi Wang

    With the global population aging at an accelerated pace, testicular aging and its associated male health issues have garnered increasing attention. Testicular aging encompasses both age-related physiological decline and premature or pathological aging caused by various pathogenic factors. It is primarily characterized by reduced androgen secretion (mainly testosterone) and impaired spermatogenesis. Leydig cells, the key cells in the testes responsible for synthesizing and secreting testosterone, play a critical role in maintaining testicular function, and their dysfunction is one of the major contributors to testicular functional decline. In recent years, stem cell technology has demonstrated significant potential in restoring Leydig cell function. Stem cells possess the ability to differentiate into Leydig-like cells, which can restore testosterone secretion, improve the testicular microenvironment, and promote the regeneration of endogenous Leydig cells. Currently, various types of stem cells, such as stem leydig cells, mesenchymal stem cells, and induced pluripotent stem cells, have been successfully directed to differentiate into Leydig-like cells. This article provides an in-depth analysis of the mechanisms by which testicular aging affects Leydig cells, with a particular focus on the application of stem cell technology in restoring Leydig cell function. Additionally, it explores potential strategies to address these issues, aiming to offer novel perspectives and approaches for the prevention and treatment of testicular aging.


  • Open Access

    Exploring the Medication Patterns of Professor Zulong Wang in Treating Sleep-Related Painful Erection Based on Data Mining

    by Hanbin Zhao, Miaomiao Ma, Yuanyuan Li, Guangzhao Wang, Wenbo Zhu, Zulong Wang

    To explore the medication patterns of Professor Zulong Wang in treating sleep-related painful erection (SRPE) through data mining, aiming to discover new therapeutic strategies for traditional Chinese medicine in managing this condition.Medical records of SRPE patients treated by Professor Zulong Wang at the First Affiliated Hospital of Henan University of Chinese Medicine from February 2021 to December 2024 were collected to establish a database. Frequency analysis, association rule analysis, and cluster analysis were employed to examine the frequency of herb use, four properties and five flavors, channel tropisms, and herb combinations.A total of 59 prescriptions meeting the criteria were included, involving 81 Chinese herbs, among which 27 herbs were used 10 or more times. The primary herb properties were cold, warm, and neutral, with bitter, sweet, and pungent flavors being most common. The herbs predominantly entered the liver, heart, spleen, and kidney channels. Forty-three commonly used herb combinations were identified, and cluster analysis revealed six core herb groups.Professor Zulong Wang primarily treats SRPE with modified Huoluo Xiaoling Dan, focusing on unblocking collaterals and relieving pain, supplemented by soothing the liver and regulating qi, resolving stasis and phlegm, nourishing yin and reducing fire, and tonifying the kidney and activating blood circulation.

  • Multi-omics genetic study revealing ferroptosis regulator CTSB driving prostate cancer progression by modulating the immune microenvironment

    by Jucai Song, Qi Zhang, Miaomiao Ma, Peng Ma, Rubing Chen, Zulong Wang

    The progression and mechanisms of drug resistance in prostate cancer are highly complex, with the ferroptosis pathway playing a critical role. We utilized multi-omics Mendelian randomization (MR) to assess the genetic causal link between ferroptosis gene/protein expression and prostate cancer, investigating potential mediation by 731 immune cell types. Furthermore, differential expression analysis, immune infiltration analysis, single-cell RNA sequencing, gene set enrichment analysis (GSEA), and drug prediction were integrated for multidimensional validation and mechanistic insight. Our results identified cathepsin B (CTSB) as a key causal risk factor associated with iron death in the development of prostate cancer (odds ratio (OR) > 1, p < 0.01). Colocalization analysis (SNP.PP.H4 > 0.95) ruled out confounding biases. Mediation MR analysis revealed that CTSB partially mediates its carcinogenic effects by regulating various immune cells, such as PD-L1 + monocytes and CD45 + T cells (OR > 1, p < 0.05). Further analysis indicated that CTSB gene/protein expression was highly expressed in normal prostate basal epithelial cells and myeloid cells, while it was downregulated in tumor tissues and neoplastic epithelial cells (p < 0.05). Notably, its expression was positively correlated with the infiltration of multiple immune cell types (cor > 0, p < 0.05). GSEA demonstrated that high CTSB expression was significantly enriched in pro-cancer pathways, including epithelial-mesenchymal transition, angiogenesis, inflammatory response, and apoptosis (normalized enrichment score (NES) > 2, false discovery rate (FDR) < 0.001). Drug prediction analyses suggested that targeting CTSB (e.g., with bortezomib) in combination with immunotherapy may represent a novel therapeutic strategy. This study provides the first evidence of the causal role of iron death-immune interactions in prostate cancer, offering new targets for precision treatment. Graphical Abstract


  • Open Access

    Global knowledge mapping and emerging research trends in non-coding RNAs related to animal and plant male sterility: A visual analysis of CiteSpace maps

    by Mingzhao Zhang, Baojun Mm Ju, Xiangyu Wang, Shuxi Zhou, Haobin Zhao, Zu Long Wang, Xiao Li

    Animal and plant male sterility is a complex and closely studied phenomenon that significantly impacts species survival and reproduction. Advances in biotechnology and molecular biology have deepened our understanding of gene expression regulation, particularly the role of noncoding RNAs (ncRNAs). This study aims to systematically review and analyze the published literature on ncRNAs in relation to both animal and plant sterility using bibliometric methods. A bibliometric analysis was conducted with CiteSpace 6.2.R6, Scimago Graphica, VOSviewer 1.6.18, and Microsoft Excel 2016 to identify research hotspots, key developments, and emerging trends. Data were retrieved from the Web of Science Core Collection on March 3, 2024, covering publications from 2005 to 2023. The analysis revealed a consistent increase in annual publications on ncRNA research in both plant and animal fields, with China and the United States leading in publication volume. Notable scholars include Professor Abu-Halima, a prominent figure in ncRNA research related to animal male sterility, and Professor Meyers, a key contributor to plant male sterility research. Journals such as PLoS ONE serve as major platforms for disseminating findings on animal male sterility, while The Plant Cell plays a similar role for plant male sterility. Analysis of cited literature and keyword trends highlighted significant themes, including gene regulation and the application of novel technologies. At present, new technologies, model organisms, and gene regulation remain major research hotspots. Meanwhile, disease diagnosis, disease treatment, and crop improvement are emerging as important directions for future research. Export